Literature DB >> 16619489

P16 protein abnormality in Epstein-Barr virus-associated gastric carcinomas.

Hitoshi Ojima1, Kana Saito, Hayato Yamauchi, Ei Yamaki, Akihito Idetu, Yasuo Hosouchi, Yasuji Nishida, Katuhiko Tukada, Hiroyuki Kato, Hiroyuki Kuwano.   

Abstract

BACKGROUND: The Epstein-Barr virus (EBV) has been detected in lymphoepithelioma of the nasopharynx and lymphoepithelioma-like carcinomas in various organs. Ten percent of gastric carcinomas, including lymphepithelioma-like carcinoma and adenocarcinoma, are associated with EBV infection. The p16 protein is a cyclin-dependent kinase (CDK) inhibitor that decelerates the cell cycle, inactivating the CDKs that phosphorylate retinoblastoma (Rb) protein.
MATERIALS AND METHODS: To clarify the relationship between p16 overexpression and EBV-associated gastric carcinomas, immunohistochemical analysis of p16 and detection of EBV by in situ hybridization were performed on 238 formalin-fixed and paraffin-embedded samples of gastric carcinomas.
RESULTS: The non-expression of p16 protein in EBV-positive and -negative carcinoma was 81.5% (53 out of 65 samples) and 26.6% (46 out of 173 samples), respectively (p < 0.001).
CONCLUSION: We suggest that the carcinogenesis of EBV-associated gastric cancers may be closely associated with a p16 abnormality.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16619489

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Role of p16 gene promoter methylation in gastric carcinogenesis: a meta-analysis.

Authors:  He-Ling Wang; Ping-Yi Zhou; Peng Liu; Yu Zhang
Journal:  Mol Biol Rep       Date:  2014-03-08       Impact factor: 2.316

2.  Protein O-glucosyltransferase 1 overexpression downregulates p16 in BT474 human breast cancer cells.

Authors:  Gang Jin; Zhigang Cao; Xilin Sun; Kai Wang; Tao Huang; Baozhong Shen
Journal:  Oncol Lett       Date:  2014-05-28       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.